The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.
Also called NCT01360567
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 102 participants
- Sponsor
- Taipei City Hospital
- Registry
-
NCT01360567
-
- Other papers using this trial's data
- Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01360567. Randomized; double masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2012-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia
- Condition
- Type 2 Diabetes
- Condition
- Hyperlipidemia
- Intervention (Dietary supplement)
- Green tea extract
- Intervention (Dietary supplement)
- Placebo
- Lead sponsor
- Taipei City Hospital
- Collaborator
- National Yang Ming Chiao Tung University
Record details
- Record id
cardio:ct-nct01360567- Content hash
dde2f42df0485b885f7b321424ebe2b704cdfc0ba4dafd59e6debbe2e61718e1